Exosomal MicroRNAs Are Diagnostic Biomarkers and Can Mediate Cell-Cell Communication in Renal Cell Carcinoma
- PMID: 28723537
- DOI: 10.1016/j.euf.2015.11.006
Exosomal MicroRNAs Are Diagnostic Biomarkers and Can Mediate Cell-Cell Communication in Renal Cell Carcinoma
Abstract
Background: Apart from an invasive biopsy, currently no tools are available to confirm the diagnosis of clear cell renal cell carcinoma (ccRCC); this resulted in approximately 30% of patients being diagnosed with metastatic disease.
Objective: To determine whether urinary microRNAs (miRNAs) can serve as biomarkers to confirm the diagnosis of ccRCC.
Design, setting, and participants: Global miRNA expression was assessed in 28 preoperative urine samples from patients with ccRCC and 18 healthy participants. The independent validation set consisted of 81 ccRCC patients, 24 patients with benign lesions, and 33 healthy participants. We extracted both cell-free and exosomal RNA for miRNA expression analysis using miRNA-specific polymerase chain reaction assays. We also investigated exosomal miRNA secretion in cell line models and performed exosome transfer between RCC and endothelial cell types.
Outcome measurements and statistical analysis: Receiver operating characteristic analysis was applied to identify the discrimination power of miRNAs.
Results and limitations: Overall, miR-126-3p combined with miR-449a or with miR-34b-5p could significantly distinguish ccRCC patients from healthy participants (miR-126-3p-miR-449a: area under the curve [AUC]: 0.84; 95% confidence interval [CI], 0.7620-0.9151; p<0.001; miR-126-3p-miR-34b-5p: AUC: 0.79; 95% CI, 0.7013-0.8815; p<0.001). The combination of miR-126-3p and miR-34b-5p was also able to distinguish small renal masses (pT1a, ≤4cm) from healthy controls (AUC: 0.79; 95% CI, 0.6848-0.8980; p<0.001). Using miR-126-3p and miR-486-5p in combination, we were able to differentiate between benign lesions and ccRCC (AUC: 0.85; 95% CI, 0.7295-0.9615; p<0.01). The expression of a number of miRNAs returned to a level comparable with health after surgery. Kidney cancer cell lines were found to secrete exosomal miR-126-3p, miR-17-5p, miR-21-3p, and miR-25-3p, and these miRNAs were found to be internalized by other cell types.
Conclusions: We identified exosomal miRNAs as potential noninvasive diagnostic urinary biomarkers for ccRCC and provided evidence that miRNAs are secreted by the tumor and can function as a tool for intercellular communication.
Patient summary: We identified urinary microRNAs that can serve as diagnostic biomarkers for clear cell renal cell carcinoma.
Keywords: Cell–cell communication; Exosomes; Noninvasive biomarker; Renal cell carcinoma; Urine; miRNAs.
Copyright © 2015 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Similar articles
-
MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.Eur Urol Focus. 2018 Apr;4(3):412-419. doi: 10.1016/j.euf.2016.09.007. Epub 2016 Oct 14. Eur Urol Focus. 2018. PMID: 28753793
-
Urinary exosomal microRNA-145-5p and microRNA-27a-3p act as noninvasive diagnostic biomarkers for diabetic kidney disease.World J Diabetes. 2024 Jan 15;15(1):92-104. doi: 10.4239/wjd.v15.i1.92. World J Diabetes. 2024. PMID: 38313849 Free PMC article.
-
Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.BMC Cancer. 2019 Feb 8;19(1):129. doi: 10.1186/s12885-019-5328-7. BMC Cancer. 2019. PMID: 30736753 Free PMC article.
-
Micro-RNAs Predict Response to Systemic Treatments in Metastatic Renal Cell Carcinoma Patients: Results from a Systematic Review of the Literature.Biomedicines. 2022 May 31;10(6):1287. doi: 10.3390/biomedicines10061287. Biomedicines. 2022. PMID: 35740309 Free PMC article. Review.
-
Non-Exosomal and Exosome-Derived miRNAs as Promising Biomarkers in Canine Mammary Cancer.Life (Basel). 2022 Apr 1;12(4):524. doi: 10.3390/life12040524. Life (Basel). 2022. PMID: 35455015 Free PMC article. Review.
Cited by
-
Diagnostic, prognostic, and therapeutic potential of exosomal microRNAs in renal cancer.Pharmacol Rep. 2024 Feb 22. doi: 10.1007/s43440-024-00568-7. Online ahead of print. Pharmacol Rep. 2024. PMID: 38388810 Review.
-
Advances in the research of exosomes in renal cell carcinoma: from mechanisms to applications.Front Immunol. 2023 Oct 24;14:1271669. doi: 10.3389/fimmu.2023.1271669. eCollection 2023. Front Immunol. 2023. PMID: 37942325 Free PMC article. Review.
-
Clinical Significance of Extracellular Vesicles in Prostate and Renal Cancer.Int J Mol Sci. 2023 Sep 28;24(19):14713. doi: 10.3390/ijms241914713. Int J Mol Sci. 2023. PMID: 37834162 Free PMC article. Review.
-
Exosomes in the Diagnosis and Treatment of Renal Cell Cancer.Int J Mol Sci. 2023 Sep 20;24(18):14356. doi: 10.3390/ijms241814356. Int J Mol Sci. 2023. PMID: 37762660 Free PMC article. Review.
-
Diagnostic liquid biopsy biomarkers in renal cell cancer.Nat Rev Urol. 2024 Mar;21(3):133-157. doi: 10.1038/s41585-023-00818-y. Epub 2023 Sep 27. Nat Rev Urol. 2024. PMID: 37758847 Review.
LinkOut - more resources
Full Text Sources
Other Literature Sources
